<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Insulin-like growth factor <z:chebi fb="7" ids="16670">peptides</z:chebi>, play an important role in regulating cell growth, differentiation, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, which has been demonstrated to promote the development of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The purpose of our study is to assess the association between circulation insulin-like growth factor <z:chebi fb="7" ids="16670">peptides</z:chebi> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) risk </plain></SENT>
<SENT sid="2" pm="."><plain>We searched Medline, EMBASE, OVID and Web of Science and picked up epidemiological studies that satisfied our inclusion criteria </plain></SENT>
<SENT sid="3" pm="."><plain>A meta-analysis of 19 epidemiological studies containing 5,155 cases and 9,420 controls related with the association of circulation insulin-like growth factor <z:chebi fb="7" ids="16670">peptides</z:chebi> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk was carried out </plain></SENT>
<SENT sid="4" pm="."><plain>Meta-analysis showed that high level IGF-I and IGF-II significantly increased <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk, (OR = 1.25, 95 % CI: 1.08-1.45 for IGF-I; OR = 1.52, 95 % CI: 1.16-2.01 for IGF-II; OR = 0.85, 95 % CI: 0.70-1.03 for IGFBP-1; OR = 0.77, 95 % CI: 0.41-1.43 for IGFBP-2 and OR = 0.88, 95 % CI: 0.71-1.10 for IGFBP-3) </plain></SENT>
<SENT sid="5" pm="."><plain>Subgroup analysis showed that the increased <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk by IGF-I was more distinguished in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> (OR = 1.35, 95 % CI: 1.04-1.75) and Caucasian (OR = 1.32, 95 % CI: 1.12-1.56) </plain></SENT>
<SENT sid="6" pm="."><plain>Our meta-analysis provides comprehensive support for a role of circulation IGF-I and IGF-II in the etiology of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>